$3.5M ACRF grant to tackle cancer complexity
28 November 2019 Walter and Eliza Hall Institute researchers have won a $3.5 million ACRF grant to conquer the biggest challenges in cancer today – predicting and improving patients’ treatment response and overcoming drug resistance. The ACRF Program…
Read MoreCSL Florey Medal recognises cell death research pioneers
27 November 2019 Walter and Eliza Hall Institute scientists Professor David Vaux AO and Professor Andreas Strasser have been jointly awarded the 2019 CSL Florey Medal for establishing a new field of research – the molecular biology of…
Read MoreThe Hon Greg Hunt MP Minister for Health: $100 million to increase clinical trial participation
29 November 2019 A joint media release with the Minister for Regional Services, Decentralisation and Local Government, the Hon Mark Coulton MP, announcing $100 million to improve the health of Australians in rural, remote and regional areas through…
Read More$520M Growth Fund To Call Melbourne Home
28 November 2019 The Andrews Labor Government has welcomed news that the Australian Business Growth Fund will be based in Melbourne, cementing its spot as the home of capital funding. The $520 million Fund will help small to…
Read MoreAMP Foundation Award bringing relief for Parkinson’s disease
29 November 2019 Dr Thushara Perera is a Research Fellow at the Bionics Institute, and we are proud to announce that he has been awarded a grant from AMP’s Tomorrow Fund. This is a highly prestigious award granted to only…
Read MorePhotosoft technology shrinks ovarian cancer by more than half in pre-clinical trial
27 November 2019 MELBOURNE (AUSTRALIA): Invion Limited (ASX: IVX) (“Invion” or “Company”) is pleased to announce the results from a pre-clinical study undertaken by Hudson Institute of Medical Research. The study used the first batch of Australian-made Photosoft™…
Read MoreExpression of Interest – Nanomedicine Working Group
28 November 2019 The nanomedicine working group is a cross-functional collaborative designed to support Australia in defining a regulatory pathway for nanomedicines and their follow-on products, nanosimilars. The focus of the group will include approval and post approval…
Read MoreAre you taking your Wi-Fi security for granted?
28 November 2019 In 2019, Wi-Fi manufacturers have introduced a number of security measures that we deem critical to our members security. We all connect to the internet and often benefit from a ‘Wireless’ connection to…
Read More“Diversity in the Workplace – Discrimination is alive and well!”
27 November 2019 By Jeremy Wurm, Managing Director, Brooker Consulting When it comes to tackling the issue of diversity (in all its forms), the life sciences sector has a way to go. Nevertheless, progress has been made in…
Read MoreDimerix holds pre-IND meeting on DMX-200 with FDA
25 November 2019 MELBOURNE, Australia: Dimerix Limited (ASX: DXB), a clinical-stage biopharmaceutical company, today confirmed that the US Food and Drug Administration (FDA) met with Dimerix for a Pre-Investigational New Drug (pre-IND) meeting. At the pre-IND meeting, the…
Read MoreCann announces revised staged approach of Mildura production facilities & market update on bank facility
21 November 2019 Cann Group Limited (ASX: CAN) today announced that it plans to complete the construction of its new medicinal cannabis production facilities near Mildura in stages (Mildura facility). Previously, the Company had intended to complete the…
Read MoreSeed Health and Atmo Biosciences announce research partnership to evaluate impact of probiotics on gut microbiome
25 November 2019 Seed Health, a US-based microbial sciences company, and Atmo Biosciences, a digital health business incubated by healthtech commercialization company Planet Innovation, have announced a research partnership to use Atmo’s ingestible gas-sensing capsule to study the…
Read More
